Thomas P. O'Neil, Chief Financial Officer at Satsuma Pharmaceuticals, Inc. (STSA), sold 1,000 shares at $27.59 ($27K) on 2020-07-01, disclosed to the SEC on 2020-07-02.
Scheduled sale ($27k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.63 | 300 | $8K | 28.9% |
| 2 | $26.70 | 394 | $11K | 39.5% |
| 3 | $27.59 | 306 | $8K | 31.7% |
| Total | $26.65 avg | 1,000 | $27K | 100% |
| Filing → |
| STSA | SELL | 2020-06-24 | $149K | — | Filing → |
| STSA | SELL | 2020-06-02 | $25K | — | Filing → |
| STSA | SELL | 2020-05-21 | $50K | — | Filing → |